Inventor
Richard Goldsmith
Inventor
South San Francisco, CA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
C07CAcyclic or carbocyclic compounds3%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds1%
C40BCombinatorial chemistry1%
PatentTitleYear
9,943,519Pharmaceutical compounds20189,487,533'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20169,309,265'Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use'20169,175,009'Benzoxepin PI3K inhibitor compounds and methods of use'20158,993,563'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20158,952,043'Benzoxepin PI3K inhibitor compounds and methods of use'20158,846,762'Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use'20148,802,670'Pharmaceutical compounds'20148,673,952'Benzoxepin PI3K inhibitor compounds and methods of use'20148,450,315'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20138,399,690'4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene compounds'20138,383,620'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20138,273,743'Quinoxaline inhibitors of the hedgehog signalling'20128,263,633'Benzoxepin PI3K inhibitor compounds and methods of use'20128,101,610'Bisamide inhibitors of hedgehog signaling'20127,928,248'Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use'20117,888,352'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20117,846,929'Phosphoinositide 3-kinase inhibitor compounds and methods of use'20106,919,369'Serine protease inhibitors'20056,472,393'Serine protease inhibitors'20025,877,278'Synthesis of N-substituted oligomers'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2005Based in Daly City, CA, US· patent location history
2002–2018Patents assigned to GENENTECH INC (18)· patent assignee history
2010–2016Based in Belmont, CA, US· patent location history
2011–2018Patents assigned to HOFFMANN LA ROCHE (10)· patent assignee history
2011–2018Based in South San Francisco, CA, US· patent location history
2012–2016Patents assigned to GOLDSMITH RICHARD (8)· patent assignee history
2012–2016Patents assigned to FOLKES Adrian (7)· patent assignee history
2012–2016Patents assigned to SUTHERLIN DANIEL P (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 18 | 2002–2018 |
| HOFFMANN LA ROCHE | 10 | 2011–2018 |
| GOLDSMITH RICHARDself | 8 | 2012–2016 |
| FOLKES Adrian | 7 | 2012–2016 |
| SUTHERLIN DANIEL P | 7 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| South San Francisco, California, US | 10 | 2011–2018 |
| Belmont, California, US | 8 | 2010–2016 |
| Daly City, California, US | 3 | 1999–2005 |